APA (7th ed.) Citation

Yang, Y., Bai, Y., Yu, H., Zhu, Q., Xie, X., & Feng, Y. RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: A systematic review and meta-analysis. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Yang, Yao, Yuping Bai, Hongli Yu, Qiang Zhu, Xiaoyu Xie, and Yuemin Feng. RECIST 1.1 Versus MRECIST for Assessment of Tumour Response to Molecular Targeted Therapies and Disease Outcomes in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. BMJ Publishing Group.

MLA (9th ed.) Citation

Yang, Yao, et al. RECIST 1.1 Versus MRECIST for Assessment of Tumour Response to Molecular Targeted Therapies and Disease Outcomes in Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. BMJ Publishing Group.